Epitel, Inc. vs Spotlight Pathology
Epitel, Inc. vs Spotlight Pathology, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Epitel, Inc. is on 58/100 and Spotlight Pathology on 42/100.
Where each one leads
Epitel, Inc.
- our overall score: 58/100 against 42/100
- agent readiness: 50/100 against 32/100
- domain rating: 40/100 against 14/100
- funding raised: $26.0M against $688K
Spotlight Pathology
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Epitel, Inc. | Spotlight Pathology |
|---|---|---|
| What it is | Epitel develops AI-driven wireless brain health technologies for remote EEG monitoring, improving diagnosis and management of neurological conditions like epilepsy. | AI software for faster and more consistent identification of blood cancers. |
| Category | HealthTech, Medical Devices, Artificial Intelligence, Biotechnology | HealthTech, Artificial Intelligence, Biotechnology, Medical Devices |
| Sells toBusiness model | B2B | B2B |
| Offering | Hardware | Software |
| Founded | 2017 | 2020 |
| Headquarters | Salt Lake City, United States | Daresbury, United Kingdom |
| Status | Active | Active |
Size, funding and growth
| Measure | Epitel, Inc. | Spotlight Pathology |
|---|---|---|
| Employees | Not published | 6 |
| Total funding | $26.0M | $688K |
| Latest round | Series B | Seed |
| Valuation | $1.1B | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Epitel, Inc. | Spotlight Pathology |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 58/100 | 42/100 |
| Traction | 37/100 | 38/100 |
| Team | 30/100 | Not published |
| Search visibility | 21/100 | 6/100 |
| Quality | 78/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (32/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 14/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Epitel, Inc. | Spotlight Pathology |
|---|---|---|
| CMS | Wix | Not detected |
Epitel, Inc. vs Spotlight Pathology: common questions
Which is better, Epitel, Inc. or Spotlight Pathology?
On our 0-100 score Epitel, Inc. rates higher (58/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Epitel, Inc. and Spotlight Pathology compare on the numbers?
Epitel, Inc. leads on our overall score (58/100 against 42/100), agent readiness (50/100 against 32/100), domain rating (40/100 against 14/100), funding raised ($26.0M against $688K).
Read the full Epitel, Inc. review and pricing or the Spotlight Pathology review and pricing. You can also browse other Epitel, Inc. alternatives we track.